Your browser doesn't support javascript.
loading
Circulating tumour DNA predicts response to anti-PD1 antibodies in metastatic melanoma.
Lee, J H; Long, G V; Boyd, S; Lo, S; Menzies, A M; Tembe, V; Guminski, A; Jakrot, V; Scolyer, R A; Mann, G J; Kefford, R F; Carlino, M S; Rizos, H.
Affiliation
  • Lee JH; Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney.
  • Long GV; Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, Sydney.
  • Boyd S; Translational Cancer Research Centre, The University of Sydney at The Westmead Institute, Sydney.
  • Lo S; Melanoma Institute Australia, Sydney.
  • Menzies AM; Sydney Medical School, The University of Sydney, Sydney.
  • Tembe V; Department of Medical Oncology, Northern Sydney Cancer Centre, Sydney.
  • Guminski A; Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney.
  • Jakrot V; Melanoma Institute Australia, Sydney.
  • Scolyer RA; Melanoma Institute Australia, Sydney.
  • Mann GJ; Sydney Medical School, The University of Sydney, Sydney.
  • Kefford RF; Department of Medical Oncology, Northern Sydney Cancer Centre, Sydney.
  • Carlino MS; Translational Cancer Research Centre, The University of Sydney at The Westmead Institute, Sydney.
  • Rizos H; Sydney Medical School, The University of Sydney, Sydney.
Ann Oncol ; 28(5): 1130-1136, 2017 May 01.
Article in En | MEDLINE | ID: mdl-28327969

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / Programmed Cell Death 1 Receptor / Circulating Tumor DNA / Melanoma Type of study: Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2017 Document type: Article Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / Programmed Cell Death 1 Receptor / Circulating Tumor DNA / Melanoma Type of study: Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2017 Document type: Article Country of publication: United kingdom